Skip to main content
. 2018 Jan 15;10(1):224–234.

Figure 1.

Figure 1

miR-132 inhibits lung cancer cell migration and invasion. A, B: Migration ability of A549 and NCI-H1299 cells transfected with the miR-132 mimic, inhibitor, or negative control using a wound-healing assay. C: Invasion ability of A549 and NCI-H1299 cells transfected with the miR-132 mimic, inhibitor, or negative control using a transwell assay. All results were obtained from three independent experiments. The migration or invasion cell number in each group was normalized to the control (* P < 0.05) or miR-132 mimics (# P < 0.05).